Skip to main content
. 2012 Sep 25;8:615. doi: 10.1038/msb.2012.43

Table 1. Characteristics of the KORA S4 cross-sectional study sample.

Clinical and laboratory parameters NGT i-IFG IGT dT2D
N 866 102 238 91
Age (years) 63.5±5.5 64.1±5.2 65.2±5.2 65.9±5.4
Sex (female) (%) 52.2 30.4 44.9 41.8
BMI (kg/m2) 27.7±4.1 29.2±4 29.6±4.1 30.2±3.9
Physical activity (% >1 h per week) 46.7 35.3 39.9 36.3
Alcohol intakea (%) 20.2 20.5 25.2 24.2
Current smoker (%) 14.8 10.8 10.9 23.1
Systolic BP (mm Hg) 131.7±18.9 138.9±17.9 140.7±19.8 146.8±21.5
HDL cholesterol (mg/dl) 60.5±16.4 55.7±15.9 55.7±15.1 50.0±15.8
LDL cholesterol (mg/dl) 154.5±39.8 152.1±37.7 155.2±38.6 146.1±44.6
Triglycerides (mg/dl) 120.7±68.3 145.0±96.0 146.6±80.0 170.6±107.1
HbA1c (%) 5.56±0.33 5.62±0.33 5.66±0.39 6.21±0.83
Fasting glucose (mg/dl) 95.6±7.1 114.2±3.7 104.5±9.7 133.2±31.7
2-h Glucose (mg/dl) 102.1±21.0 109.3±18.7 163.4±16.4 232.1±63.7
Fasting insulin (μU/ml) 10.48±7.28 16.26±9.67 13.92±9.53 17.70±12.61

NGT, normal glucose tolerance; i-IFG, isolated impaired fasting glucose; IGT, impaired glucose tolerance; dT2D, newly diagnosed type 2 diabetes; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

Percentages of individuals or means±s.d. are given for each variable and each group (NGT, i-IFG, IGT and dT2D).

a⩾20 g/day for women; ⩾40 g/day for men.